{"id":"https://openalex.org/W77345372","doi":"https://doi.org/10.1002/cpt1971121117","title":"Comparative clinical therapeutic trial with two hypolipidemic drugs: Clofibrate and nafenopin","display_name":"Comparative clinical therapeutic trial with two hypolipidemic drugs: Clofibrate and nafenopin","alternate_titles":[],"publication_year":1971,"publication_date":"1971-01-01","ids":{"openalex":"https://openalex.org/W77345372","doi":"https://doi.org/10.1002/cpt1971121117","mag":"77345372","pmid":"https://pubmed.ncbi.nlm.nih.gov/5099889"},"language":"en","primary_location":{"id":"doi:10.1002/cpt1971121117","doi":"https://doi.org/10.1002/cpt1971121117","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpt1971121117","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W77345372"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048442493","display_name":"Carlos A. Dujovne","orcid":"https://orcid.org/0000-0002-8376-3198","observed_orcids":["https://orcid.org/0000-0002-8376-3198"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carlos A. Dujovne","raw_affiliation_strings":["Baltimore, Md. Division of Clinical Pharmacology, Department of Medicine, lohns Hopkins University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baltimore, Md. Division of Clinical Pharmacology, Department of Medicine, lohns Hopkins University School of Medicine","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Peter Weiss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Weiss","raw_affiliation_strings":["Baltimore, Md. Division of Clinical Pharmacology, Department of Medicine, lohns Hopkins University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baltimore, Md. Division of Clinical Pharmacology, Department of Medicine, lohns Hopkins University School of Medicine","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111844320","display_name":"Joseph R. Bianchine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joseph R. Bianchine","raw_affiliation_strings":["Baltimore, Md. Division of Clinical Pharmacology, Department of Medicine, lohns Hopkins University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baltimore, Md. Division of Clinical Pharmacology, Department of Medicine, lohns Hopkins University School of Medicine","institution_ids":["https://openalex.org/I145311948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I145311948"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":2.3826,"has_fulltext":false,"cited_by_count":27,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.86798165,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"1","first_page":"117","last_page":"125"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.8711000084877014,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.8711000084877014,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.12409999966621399,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clofibrate","display_name":"clofibrate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/nafenopin","display_name":"nafenopin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/lipid-lowering-drugs","display_name":"lipid-lowering drugs","score":0.9049999713897705},{"id":"https://openalex.org/keywords/hyperlipidemia","display_name":"hyperlipidemia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/serum-cholesterol","display_name":"serum cholesterol","score":0.968999981880188},{"id":"https://openalex.org/keywords/serum-triglycerides","display_name":"serum triglycerides","score":0.9710000157356262},{"id":"https://openalex.org/keywords/triglyceride-lowering","display_name":"triglyceride lowering","score":0.722000002861023},{"id":"https://openalex.org/keywords/drug-comparison","display_name":"drug comparison","score":0.7129999995231628},{"id":"https://openalex.org/keywords/elevated-liver-enzymes","display_name":"elevated liver enzymes","score":0.8669999837875366},{"id":"https://openalex.org/keywords/alkaline-phosphatase","display_name":"alkaline phosphatase","score":0.8349999785423279}],"concepts":[{"id":"https://openalex.org/C2779496979","wikidata":"https://www.wikidata.org/wiki/Q2701912","display_name":"Clofibrate","level":2,"score":0.9836728572845459},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.6420294642448425},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.615022599697113},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5980884432792664},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5530456304550171},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.43765872716903687},{"id":"https://openalex.org/C2993922820","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Serum cholesterol","level":3,"score":0.42441245913505554},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4215629994869232},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41147294640541077},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3958478569984436},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.38279712200164795}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000469","descriptor_name":"Alkaline Phosphatase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000637","descriptor_name":"Transaminases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001663","descriptor_name":"Bilirubin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002621","descriptor_name":"Chemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002994","descriptor_name":"Clofibrate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003402","descriptor_name":"Creatine Kinase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055598","descriptor_name":"Chemical Phenomena","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/cpt1971121117","doi":"https://doi.org/10.1002/cpt1971121117","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpt1971121117","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:5099889","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/5099889","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W142578100","https://openalex.org/W2419227334","https://openalex.org/W2017977073","https://openalex.org/W2410660155","https://openalex.org/W2432321339","https://openalex.org/W2023551016","https://openalex.org/W2408817981","https://openalex.org/W635957507","https://openalex.org/W2406848229","https://openalex.org/W2054700251"],"abstract_inverted_index":{"The":[0,36],"effects":[1,58],"of":[2,19,59],"clofibrate":[3],"and":[4,42,99,113,121],"nafenopin":[5,66,98],"were":[6,63],"compared":[7],"in":[8,44,56,83,109,116],"hyperlipidemic":[9],"patients.":[10],"Each":[11],"patient":[12],"was":[13,71,77,100],"randomly":[14],"assigned":[15],"to":[16],"take":[17],"one":[18,73],"the":[20,28,33,50,57,60,67,103,110],"drugs":[21,38,62],"first":[22],"for":[23,31],"12":[24],"weeks":[25],"followed":[26],"by":[27],"other":[29],"drug":[30],"approximately":[32],"same":[34],"period.":[35],"two":[37,61],"reduced":[39],"serum":[40,84,89,111],"cholesterol":[41],"triglyceride":[43],"all":[45],"15":[46],"patients":[47,118],"who":[48],"completed":[49],"study.":[51,104],"No":[52],"statistically":[53],"significant":[54],"differences":[55],"seen.":[64],"With":[65],"maximum":[68],"hypotriglyceridemic":[69],"effect":[70],"at":[72],"month;":[74],"subsequently":[75],"there":[76],"a":[78],"slight":[79],"but":[80],"progressive":[81],"increase":[82],"triglycerides.":[85,90],"Clofibrate":[86],"progressively":[87],"decreased":[88],"One":[91],"subject":[92],"developed":[93],"marked":[94],"hypertransaminasemia":[95],"while":[96],"receiving":[97],"withdrawn":[101],"from":[102,106],"Changes":[105],"base":[107],"Zine":[108],"transaminases":[112],"alkaline":[114],"phosphatase":[115],"some":[117],"are":[119],"described":[120],"discussed.":[122]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W77345372","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
